2022
DOI: 10.1016/j.apjon.2022.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Cancer cachexia syndrome: Reflecting on 20 years of providing cancer cachexia care as the leader of an interdisciplinary team in an Australian cancer center

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Cancer-associated adipocytes have been found to promote lipid accumulation ( 35 ). In the case of malignant melanoma, the tumor secreted an inhibitor of adipose LPL termed melanoma cachexia factor, which caused the inhibition of extracellular lipolysis ( 36 ). Activation of the transmembrane channel for exogenous free fatty acid uptake (CD36) and LPL (a key enzyme for extracellular lipolysis) confirmed the disposition of extracellular lipid stores and lipolysis in cells.…”
Section: Discussionmentioning
confidence: 99%
“…Cancer-associated adipocytes have been found to promote lipid accumulation ( 35 ). In the case of malignant melanoma, the tumor secreted an inhibitor of adipose LPL termed melanoma cachexia factor, which caused the inhibition of extracellular lipolysis ( 36 ). Activation of the transmembrane channel for exogenous free fatty acid uptake (CD36) and LPL (a key enzyme for extracellular lipolysis) confirmed the disposition of extracellular lipid stores and lipolysis in cells.…”
Section: Discussionmentioning
confidence: 99%